Trial record 1 of 1 for:    AB08026
Previous Study | Return to List | Next Study

A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Dacarbazine in the Treatment of Patients With Non-Resectable or Metastatic Stage 3 or Stage 4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of C-Kit

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by AB Science
Information provided by (Responsible Party):
AB Science Identifier:
First received: August 6, 2010
Last updated: October 7, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)